Pioneering mRNA technology - Moderna
Moderna to Begin Testing Its Coronavirus Vaccine in Children - The New York Times
Moderna vaccine: Here are some of the limitations India may face with Moderna and Pfizer's COVID vaccine - Neck-to-neck race | The Economic Times
Moderna COVID-19 Vaccine Office Hours: Pediatric and Adolescent Indications | Moderna, Inc.
FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk, company says
Moderna vaccine set for imminent US approval, as Europe battles surge – EURACTIV.com
Moderna's mRNA Cancer Vaccine Shows Promise in Preliminary Study - WSJ
Moderna failed to disclose federal funding for patent applications, advocates say
The comms plan behind Moderna's COVID-19 vaccine | PR Week
COVID shots made Moderna biotech's biggest star, but what now? - The Boston Globe
Moderna, Novavax developing combined COVID-19, flu shots | CBC News
Moderna considering creating an mRNA monkeypox vaccine amid growing demand for shots - ABC News
Moderna executives have cashed out $89M in shares this year
Selling stock at a clip, top Moderna doctor gets $1 million richer each week
Moderna shells out for CEO security as its COVID-19 vaccine grabs the spotlight | Fierce Pharma
Moderna CEO says its COVID vaccine will not be ready before election - CBS News
Moderna to partner with ElevateBio on CRISPR research
Hopes of Covid vaccine for more than 1bn people by end of 2021 | Coronavirus | The Guardian
Moderna bivalent Covid vaccine appears to work against omicron subvariants BA.4 and BA.5
Moderna joins Association of the British Pharmaceutical Industry
Early Data Show Moderna's Coronavirus Vaccine Is 94.5% Effective - The New York Times
Moderna Therapeutics Clinical Manufacturing Facility, Norwood
Science by press release': Sudden rise of vaccine developer Moderna rankles some in scientific establishment - ABC News
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Moderna failed to disclose federal support in vaccine patents, researchers say - The Washington Post
FDA: Moderna COVID-19 Vaccine Is 94% Effective : Shots - Health News : NPR
Moderna says flu shot misses early success bar, but expects 2024 revenue | Reuters
When the spotlight found Moderna, they were ready': How the Cambridge biotech company became a world renowned success story - The Boston Globe
